Can the NHS keep up? Preparing for the next wave of neurological innovation

For decades, many of these conditions have been considered largely untreatable. But with a growing number of therapies showing meaningful clinical impact and moving towards key regulatory and access decision points, this is beginning to change.

However, scientific progress alone will not translate into better outcomes for people living with neurological conditions unless paired with a system that is ready to deliver these innovations.

To explore this challenge, WA Communications partnered with the Neurological Alliance to analyse the late-stage neurological treatment pipeline and assess whether the health system in England in prepared for what comes next.

Our work focused both on the scale of innovation, as well as what these advances will mean in practice for patients, clinicians and the wider health system. Our engagement with stakeholders across the sector highlighted where the system is working well and where it risks falling short. Rather than examining individual parts of the pathway in isolation, the aim was to understand how the system functions as a whole.

Across neurological conditions, treatments are complex, patient populations are small, and outcomes are harder to measure using traditional approaches. Yet NICE and service providers continue to operate on assumptions better suited to high-volume, well-understood conditions.

This creates a consistent set of predictable friction points for emerging innovation in neurology, and the result is a growing disconnect between innovation and implementation.

Future-proofing neurology services: What emerging treatments mean for people, services and policy in England sets out how this can be addressed. Drawing on pipeline analysis and cross-sector insight, the report argues for a shift from reactive adoption to proactive system design.

This includes more systematic use of managed access agreements and a broader acceptance of real-world and patient-reported outcomes to better reflect the realities of neurological conditions. But it also means aligning service planning with the pipeline itself, using upcoming opportunities such as the NHS Long Term Workforce Plan and pushing for the development of a modern service framework for neurology which would provide a mechanism to ensure services are designed with future treatments in mind rather than retrofitted after the fact.

By combining detailed pipeline analysis with real-world insight, this work provides a clearer picture of where the system is falling short, and what it will take to be ready for what’s coming next.

Georgina Carr, Chief Executive at Neurological Alliance said:

“Neurological Alliance was pleased to work with WA Communications on this important piece of work. WA’s support in analysing and deciphering the neurological treatment pipeline, together with the insight from across our membership, has highlighted both the scale of the opportunity and the urgent need for the system to be ready to deliver it. Ensuring that people affected by neurological conditions can benefit from new and emerging treatments must be a priority now.”

For more information on how WA Health can support your organisation to build cross-sector consensus, generate insight, and shape the conditions for successful adoption of innovation, get in touch with Catrin Hughes at [email protected].